Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease

Neurological Sciences

Volumn 34, Issue 12, 2013, Pages 2117-2121

  Arikanoglu, Adalet ^a   Akil, Esref ^a   Varol, Sefer ^a   Yucel, Yavuz ^a   Yuksel, Hatice ^a   Cevik, Mehmet Ugur ^a   Palanci, Yilmaz ^a   Unan, Fatma ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Cognitive performance; Oxidative stress; Prolidase

Indexed keywords

PROLINE DIPEPTIDASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEALTH STATUS; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS;

AGED; ALZHEIMER DISEASE; ANTIOXIDANTS; DEMENTIA; DIPEPTIDASES; FEMALE; HUMANS; MALE; OXIDANTS; OXIDATIVE STRESS;

EID: 84890571330     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1346-4     Document Type: Article

References (27)

1. Mark RJ, Blanc EM, Mattson MP (1996) Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol Neurobiol 12:211-224
2. Varadarajan S, Yatin S, Aksenova M, Butterfield DA (2000) Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130:184-208
3. Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M, Fenoglio C, Venturelli E, Baron P, Bresolin N, Scarpini E (2006) Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 27:262-269
4. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G (2004) Oxidative stress signaling in Alzheimer's disease. Brain Res 1000:32-39
5. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9:133-146
6. Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103-1111
7. Migliore L, Coppedè F (2009) Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res 31:73-84
8. Puertas MC, Martínez-Martos JM, Cobo MP, Carrera MP, Mayas MD, Ramírez-Expósito MJ (2012) Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia. Exp Gerontol 47:625-630
9. Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112-119
10. Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G (1994) Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 79:13-18
11. Savas M, Yeni E, Verit A, Gulum M, Aksoy N, Ciftci H, Celik H, Altunkol A, Oncel H (2010) Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction. Clinics 65:1311-1314
12. Delwing D, Chiarani F, Bavaresco CS, Wannmacher CM, Wajner M, Dutra-Filho CS, Wyse AT (2005) Protective effect of antioxidants on brain oxidative damage caused by proline administration. Neurosci Res 52:69-74
13. Cohen S, Nadler J (1997) Proline-induced potentiation of glutamate transmission. Brain Res 761:271-282
14. Revett TJ, Baker GB, Jhamandas J, Kar S (2013) Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci 38:6-23
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944
16. Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline colorimetric determination: application to imminodipeptiduria. Clin Chim Acta 125:193-205
17. Chinard FP (1952) Photometric estimation of proline and ornithine. J Biol Chem 199:91-95
18. Endo F, Matsuda I, Ogata A, Tanaka S (1982) Human erythrocyte prolidase and prolidase deficiency. Pediatr Res 16:227-231
19. Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M (2007) Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 274:339-344
20. Selek S, Altindag A, Saracoglu G, Celik H, Aksoy N (2011) Prolidase activity and its diagnostic performance in bipolar disorder. J Affect Disord 129:84-86
21. Cohen SM, Nadler JV (1997) Proline-induced potentiation of glutamate transmission. Brain Res 761:271-282
22. Farber NB, Newcomer JW, Olney JW (1998) The glutamate synapse in neuropsychiatric disorders: focus on schizophrenia and Alzheimer's disease. Prog Brain Res 116:421-437
23. Engelhart MJ, Geerlings MI, van Ruitenberg A, Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:3223-3229
24. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ, Memantine Study Group (2003) Memantine treatment in patients with moderate-to-severe AD. N Engl J Med 348:1333-1341
25. Uzar E, Tamam Y, Evliyaoglu O, Tuzcu A, Beyaz C, Acar A, AydIn B, Tasdemir N (2012) Serum prolidase activity and oxidative status in patients with diabetic neuropathy. Neurol Sci 33:875-880
26. Gencer M, Aksoy N, Dagli EC, Uzer E, Aksoy S, Selek S, Celik H, Cakir H (2011) Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease. J Clin Lab Anal 25:8-13
27. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM, Moreira WL, Loureiro AP, de Souza-Talarico JN, Smid J, Porto CS, Bottino CM, Nitrini R, Barros SB, Camarini R, Marcourakis T (2011) Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 261:59-68